ORTEXORTEX News
Tracking SMBK? Get live short interest, options flow, and signals on ORTEX.Sign up free →
SM
ConfluenceSMBK

Raymond James Cuts SMBK After Earnings Caution

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 21 Oct 2026, 10:18

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Raymond James downgraded SmartFinancial, Inc. this morning, stepping back from its Strong Buy rating the day after Q3 results. The move lands alongside a put/call ratio still running at extreme levels and a short position that has nearly doubled over the past month.

Why this matters: Four distinct data signals are now pointing in the same direction at once. A high-conviction brokerage downgrade, persistent options defensiveness, a 60% month-on-month short buildup, and a falling stock price form a coherent post-earnings picture.

The Analyst Move

Steve Moss at Raymond James lowered his rating to Outperform from Strong Buy and cut his price target to $56 from $58. At the October 20 close of $50.12, the new target implies 11.7% upside. That is still positive, but the direction of travel matters: the last time Moss touched the stock, in July 2025, he reiterated Strong Buy and raised his target. The downgrade follows a Q3 report that produced a one-day move of -1.4%. Benchmark still holds a Buy with a $60 target. Stephens carries Equal-Weight at $47. The average across covered analysts sits at $52.54.

Options Signal Holds Elevated

The put/call ratio was 5.33 on October 20, three standard deviations above its 20-day mean of 0.66. For most of September, the PCR sat below 0.19. The jump was timed to earnings and has not reverted. That persistence, a day after the print, is worth noting. Before earnings it could be read as hedging. After the result, a PCR still at 5.33 suggests options positioning has not unwound.

Corroborating Context

Short interest sits at 3.7% of free float, up 60% over the past month. The bulk of that build happened in early October, ahead of the earnings date. This is consistent with tactical pre-earnings positioning rather than a structural bear thesis. Availability in the lending market remains extremely loose at 6,596%. Shares are not hard to borrow. The cost to borrow has fallen to 0.21%, down 52% over the past week. There is no squeeze pressure from the lending side.

FDIC call report data via the ORTEX Alt Data layer shows net loans and leases rising for nine consecutive quarters and total assets up for eight, both as of the April 2026 period. That dataset has not yet been tested as a lead indicator for the company's reported figures. BlackRock added 183,638 shares as of September 30, making it the largest institutional holder at 8.6% of shares.

Data Summary

  • Raymond James: Outperform, $56 target (from Strong Buy, $58)
  • Stock close: $50.12, down 0.8% on the day, down 3% over one month
  • PCR: 5.33, z-score 3.0 above 20-day mean of 0.66
  • SI % of free float: 3.7%, up 60% over one month
  • Availability: 6,596%, cost to borrow 0.21%
  • Next earnings: January 15, 2027

Stocks in this article

See the live data behind this article on ORTEX.

Open SMBK on ORTEX →

How this article was generated

Generated
21 Oct 2026, 10:21
Data as of
21 Oct 2026, 10:18
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.